Mass High Tech - April 18, 2008

VisEn Medical lands $5M more from Merck, Flagship
Mass High Tech

Officials at VisEn Medical Inc. say that the medical imaging technology company has landed a $5 million tranche of Series B financing.

Merck Capital Ventures and Flagship Ventures co-led the expansion of the VC round, which initially raised $7 million in November 2007, bringing the total VC financing round to $12 million. VisEn said it would use the additional financing to further advance its proprietary fluorescence in vivo imaging product pipelines, and to expand its commercial applications.

VisEn was founded in 2000 based on fluorescence in vivo imaging technologies initially developed at Massachusetts General Hospital and Harvard Medical School. Privately held VisEn is headquartered in Woburn.